Cart
sales@molnova.com
Emeramide
CAS No. 351994-94-0
Emeramide( BDTH2 )
Catalog No. M24302 CAS No. 351994-94-0
Emeramide is a thiol-redox antioxidant. It is also a heavy metal chelator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 43 | In Stock |
|
| 500MG | 88 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEmeramide
-
NoteResearch use only, not for human use.
-
Brief DescriptionEmeramide is a thiol-redox antioxidant. It is also a heavy metal chelator.
-
DescriptionEmeramide is a thiol-redox antioxidant. It is also a heavy metal chelator.
-
In Vitro——
-
In Vivo——
-
SynonymsBDTH2
-
PathwayImmunology/Inflammation
-
TargetROS
-
RecptorReactive Oxygen Species
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number351994-94-0
-
Formula Weight284.4
-
Molecular FormulaC12H16N2O2S2
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (351.62 mM; Need ultrasonic and warming);H2O:< 0.1 mg/mL (insoluble)
-
SMILESO=C(C1=CC=CC(C(NCCS)=O)=C1)NCCS
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Secor JD, et al. Novel lipid-soluble thiol-redox antioxidant and heavy metal chelator, N,N'-bis(2-mercaptoethyl)isophthalamide (NBMI) and phospholipase D-specific inhibitor, 5-fluoro-2-indolyl des-chlorohalopemide (FIPI) attenuate mercury-induced lipid signaling leading to protection against cytotoxicity in aortic endothelial cells. Int J Toxicol. 2011 Dec;30(6):619-38.
molnova catalog
related products
-
N-Acetyl-D-cysteine
N-Acetyl-D-cysteine has antioxidant activities and scavenges ROS through the reaction with its thiol group.
-
5-Hydroxyoxindole
5-Hydroxyoxindole has been identified as a urinary metabolite of indole, which is produced from tryptophane via the tryptophanase activity of gut bacteria.
-
CL097
CL097 is an effective agonist of TLR7 and TLR8. CL097 induces pro-inflammatory cytokines in macrophages and NADPH oxidase priming, thereby increasing the fMLF-stimulated ROS production.
